进行中(不再招募) NCT07395570

CADe系统侦测胃部肿瘤之疗效

胃癌不适用I 期II 期

胃癌仍是全球第五常见的癌症,其癌症相关死亡率亦排名第五,每年造成超过650,000人死亡。胃癌的存活与确诊时的期数直接相关,早期癌症的存活明显较佳。第I期胃癌患者的五年生存率一般超过90%。

适应症:Gastric Neoplasia

入组条件

纳入标准

  • Age \>=18
  • Deemed at high risk of gastric cancer, defined as below:
  • Family history of stomach cancer (1st degree relative) for screening, or
  • Known gastric atrophy/ intestinal metaplasia requiring surveillance, or
  • Suspicious lesion for repeat diagnostic OGD, or
  • History of gastric dysplasia / early gastric cancer with endoscopic resection for surveillance
  • Newly diagnosed early gastric cancer, workup for synchronous cancers

排除标准

  • History of gastrectomy (For any reason, including benign and malignant disease)
  • Patient who refused to participate
  • Patients deemed not fit for consent, including minor patients
  • Pregnancy
  • Other cases deemed by the examining physician as unsuitable for safe treatment

入组条件维持 ClinicalTrials.gov 原始英文登记资料,实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源:ClinicalTrials.gov,每两周自动更新,最后同步:2026年10月8日。